Twin Tree Management, LP Summit Therapeutics Inc. Transaction History
Twin Tree Management, LP
- $51.8 Billion
- Q2 2025
A detailed history of Twin Tree Management, LP transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Twin Tree Management, LP holds 38,200 shares of SMMT stock, worth $714,722. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,200
Previous 105,600
63.83%
Holding current value
$714,722
Previous $2.04 Million
60.14%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding SMMT
# of Institutions
270Shares Held
90.8MCall Options Held
4.71MPut Options Held
3.17M-
Baker Bros. Advisors LP New York, NY33.7MShares$631 Million7.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.67MShares$162 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$148 Million0.0% of portfolio
-
State Street Corp Boston, MA4.02MShares$75.2 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.91MShares$73.1 Million0.01% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.76B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...